Stribild Tablet, Film Coated
Product Images NDC 61958-1201

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Stribild (NDC 61958-1201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Stribild 01)

Stribild film-coated oral tablets by Gilead Sciences, Inc., containing elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate. The blue/brown blister card shows 14 tablets with the imprint 'Stribild' on each tablet. The pack is labeled with the NDC 61958-1201.*

FDA Label Image

Chemical Structure (Stribild 02)

Chemical structure of the active ingredient elvitegravir, shown as a molecular diagram with labeled functional groups, including hydroxyl, methyl, fluorophenyl, and chlorine substituents.*

FDA Label Image

Chemical Structure (Stribild 03)

Chemical structure of elvitegravir, one of the active ingredients in Stribild tablets. The diagram depicts the molecular formula with rings and bonds characteristic of elvitegravir's chemical composition.*

FDA Label Image

Chemical Structure (Stribild 04)

Chemical structure of the active ingredient elvitegravir, as indicated in the product data for Stribild tablets.*

FDA Label Image

Chemical Structure (Stribild 05)

Chemical structure of the active ingredients elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate as part of the combination tablet Stribild by Gilead Sciences, Inc.*

FDA Label Image

Principal Display Panel (30 Tablet Bottle Label)

Stribild 150 mg/150 mg/200 mg/300 mg film-coated oral tablets packaging label. The label displays the proprietary name Stribild and lists the active ingredients elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate with corresponding strengths. The labeler is Gilead Sciences, Inc., and the product NDC is 61958-1201.*

FDA Label Image

Stribild 07

Stribild tablets label showing elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate as active ingredients. The strength is 150 mg/150 mg/200 mg/300 mg per tablet. The label includes a count of 30 film-coated tablets, storage instructions, manufacturer Gilead Sciences, Inc., and an alert note to pharmacists regarding medication interactions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.